This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

Public Law

Articles

Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products?

Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products?

Peter Rudd-Clarke, a Partner in Osborne Clarke’s life sciences and healthcare team, Tamara Quinn, a Director in Osborne Clarke’s AI, data and IP knowledge team, and Julia Smith, an associate in Osborne Clarke’s commercial team, provide a detailed breakdown of the approach being taken to artificial intelligence within the life sciences sector and the upcoming regulatory developments
Transparency International sheds light on public procurement during the pandemic

Transparency International sheds light on public procurement during the pandemic

Following the publication of Transparency International UK’s report on corruption red flags in Covid-19 public procurement, Tamlyn Edmonds and Jack Walsh from Edmonds Marshall McMahon discuss the claims made in the report and whether the impending changes being brought in by the Procurement Act 2023 will address the problem in future